Vatinoxan

DB19781ExperimentalSmall molecule

Vatinoxan is a small molecule drug. The usage of the INN stem '-oxan(e)' in the name indicates that Vatinoxan is a benzodioxane derivative. Vatinoxan has a monoisotopic molecular weight of...

Mechanism: Pharmacologically active on Alpha-2 adrenergic receptors
Curator reviewed
Formula / weight: C₂₀H₂₆N₄O₄S · 418.51 g/mol (avg)
Code names: L-659066 · MK-467 FREE BASE

Resolves to

Compound

UNII342EYN0QFDCAS114914-42-0ChEMBLCHEMBL4298165ChEBI757574PubChem163952

Clinical / RWD

RxNorm2601584

Structure

InChIKeyGTBKISRCRQUFNL-OXJNMPFZSA-NSMILES[H][C@@]12C[C@@]3(CNC(=O)N3CCNS(C)(=O)=O)CCN1CCC1=C2OC2=CC=CC=C12

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

13+ReferencesStructured and connected to the statements they support

Which companies are running trials of Vatinoxan, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account